The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non–Small Cell Lung Cancer: A Meta-Analysis
BackgroundTo assess the effect of asymptomatic and/or treated brain metastases (BMs) on the efficacy of immune checkpoint inhibitors (ICIs) in metastatic non-small cell lung cancer (NSCLC).Patients and MethodsPubMed, Embase, Cochrane Library, Web of Science, and recent meetings were searched for ran...
Main Authors: | Sihan Li, Hongwei Zhang, Tingting Liu, Jun Chen, Jun Dang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.702924/full |
Similar Items
-
The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis
by: Linzheng Dai, et al.
Published: (2021-08-01) -
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2018-10-01) -
Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
by: Hsiao-Ling Chen, et al.
Published: (2021-03-01) -
PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases
by: Sun C, et al.
Published: (2020-12-01) -
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting
by: Marcus Skribek, et al.
Published: (2020-12-01)